MarketPeel
Insider Trading Intelligence
JS

Jeffrey Scott Sherman

NEO
CHIEF FINANCIAL OFFICER · NEOGENOMICS INC · CIK 0001463145
FILING MIX · LIFETIME61%/39%
BUYS
23
SELLS
15
TOTAL VALUE
$356.5K
COMPANIES
2
ACTIVE SINCE
Jan 2022
HOLDINGS NOW
458,920
AVG SELL PX
$14.86
TRADE KIND
SHOWING 38 / 38
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizons · 3 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Jeffrey Scott Sherman, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+100.00%+9.10%+0.74%+8.36%+8.36%
14d2+100.00%+8.22%+2.84%+5.38%+5.38%
30d2+50.00%+19.24%+3.43%+15.80%+15.80%
60d2+50.00%+31.00%+7.56%+23.44%+23.44%
90d2+50.00%+23.41%+9.12%+14.30%+14.30%
180d2+100.00%+78.87%+15.59%+63.27%+63.27%
1y2(1 pending)+100.00%+22.60%+27.15%-4.55%-4.55%
2y2(2 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
NEO · 223,792 shares · as of Feb 23, 2026
062,292124,585186,877249,1692023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 23 buys / 15 sellsCOVERAGE · 17 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
NEO
NEOGENOMICS INC
SALE
Chief Financial Officer
15,53515,536Feb 23, 2026Feb 24, 2026View →
NEO
NEOGENOMICS INC
SALE
Chief Financial Officer
3,783220,009Feb 23, 2026Feb 24, 2026View →
NEO
NEOGENOMICS INC
PURCHASE
Chief Financial Officer
15,535223,792Feb 23, 2026Feb 24, 2026View →
NEO
NEOGENOMICS INC
SALE
Chief Financial Officer
10,729208,257Feb 21, 2026Feb 24, 2026View →
NEO
NEOGENOMICS INC
PURCHASE
Chief Financial Officer
42,158218,986Feb 21, 2026Feb 24, 2026View →
NEO
NEOGENOMICS INC
SALE
Chief Financial Officer
42,15884,318Feb 21, 2026Feb 24, 2026View →
NEO
NEOGENOMICS INC
SALE
Chief Financial Officer
11,938176,394Dec 7, 2025Dec 9, 2025View →
NEO
NEOGENOMICS INC
PURCHASE
Chief Financial Officer
20,000$5.62$112.3K188,332Aug 6, 2025Aug 6, 2025View →
NEO
NEOGENOMICS INC
SALE
Chief Financial Officer
13,00513,006May 11, 2025May 13, 2025View →
NEO
NEOGENOMICS INC
PURCHASE
Chief Financial Officer
13,005171,499May 11, 2025May 13, 2025View →
NEO
NEOGENOMICS INC
SALE
Chief Financial Officer
3,167168,332May 11, 2025May 13, 2025View →
NEO
NEOGENOMICS INC
PURCHASE
Chief Financial Officer
20,000$7.51$150.1K158,494May 2, 2025May 6, 2025View →
NEO
NEOGENOMICS INC
SALE
Chief Financial Officer
4,207137,064Feb 23, 2025Feb 25, 2025View →
NEO
NEOGENOMICS INC
SALE
Chief Financial Officer
15,53531,071Feb 23, 2025Feb 25, 2025View →
NEO
NEOGENOMICS INC
PURCHASE
Chief Financial Officer
15,535141,271Feb 23, 2025Feb 25, 2025View →
NEO
NEOGENOMICS INC
PURCHASEGRANT
Stock grant
214,900214,900Feb 21, 2025Feb 25, 2025View →
NEO
NEOGENOMICS INC
PURCHASEGRANT
Stock grant
126,476126,476Feb 21, 2025Feb 25, 2025View →
NEO
NEOGENOMICS INC
PURCHASEGRANT
Stock grant
59,38259,382Jan 14, 2025Jan 16, 2025View →
NEO
NEOGENOMICS INC
SALE
Chief Financial Officer
11,746123,754Dec 7, 2024Dec 10, 2024View →
NEO
NEOGENOMICS INC
SALE
Chief Financial Officer
13,00526,011May 11, 2024Dec 3, 2024View →
NEO
NEOGENOMICS INC
PURCHASE
Chief Financial Officer
13,005138,667May 11, 2024Dec 3, 2024View →
NEO
NEOGENOMICS INC
SALE
Chief Financial Officer
3,167$14.86$47.1K135,500May 11, 2024Dec 3, 2024View →
NEO
NEOGENOMICS INC
PURCHASE
Chief Financial Officer
13,005138,667May 11, 2024May 14, 2024View →
NEO
NEOGENOMICS INC
SALE
Chief Financial Officer
3,167$14.86$47.1K135,500May 11, 2024May 14, 2024View →
NEO
NEOGENOMICS INC
PURCHASE
Chief Financial Officer
13,005148,505May 11, 2024May 14, 2024View →
NEO
NEOGENOMICS INC
SALE
Chief Financial Officer
13,00526,011May 11, 2024May 14, 2024View →
NEO
NEOGENOMICS INC
PURCHASEGRANT
Stock grant
46,60646,606Feb 23, 2024Feb 27, 2024View →
NEO
NEOGENOMICS INC
PURCHASEGRANT
Stock grant
77,91377,913Feb 23, 2024Feb 27, 2024View →
NEO
NEOGENOMICS INC
PURCHASEGRANT
Stock grant
46,60646,606Feb 23, 2024Feb 27, 2024View →
NEO
NEOGENOMICS INC
SALE
Chief Financial Officer
8,147125,662Dec 7, 2023Dec 11, 2023View →
NEO
NEOGENOMICS INC
PURCHASEGRANT
Stock grant
73,01673,016May 11, 2023May 15, 2023View →
NEO
NEOGENOMICS INC
PURCHASEGRANT
Stock grant
39,01639,016May 11, 2023May 15, 2023View →
NEO
NEOGENOMICS INC
PURCHASEGRANT
Stock grant
39,01639,016May 11, 2023May 15, 2023View →
NEO
NEOGENOMICS INC
PURCHASEGRANT
Stock grant
249,169249,169Dec 5, 2022Dec 7, 2022View →
NEO
NEOGENOMICS INC
PURCHASEGRANT
Stock grant
89,206133,809Dec 5, 2022Dec 7, 2022View →
NEO
NEOGENOMICS INC
PURCHASEGRANT
Stock grant
44,60344,603Dec 5, 2022Dec 7, 2022View →
PRVA
PRIVIA HEALTH GROUP, INC.
PURCHASEGRANT
Stock grant
61,30761,307Jan 5, 2022Jan 7, 2022View →
PRVA
PRIVIA HEALTH GROUP, INC.
PURCHASEGRANT
Stock grant
235,128235,128Jan 5, 2022Jan 7, 2022View →
Other insiders · NEO
Loading peer insiders…
About this filer
CIK 0001463145
ROLE
Chief Financial Officer
PRIMARY
NEO
COMPANIES
2
ACTIVE SINCE
Jan 2022
MARKETPEEL · /INSIDER/0001463145DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback